FTSE All-Share
|
5 021,32
|
35,86
|
0,72 %
|
Analysen zu FTSE All-Share-Werten
| 22.02.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
| 22.02.24 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 22.02.24 | BP Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.02.24 | HSBC Holdings Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.02.24 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
| 22.02.24 | National Grid Neutral | Goldman Sachs Group Inc. | |
| 22.02.24 | Glencore Hold | Deutsche Bank AG | |
| 22.02.24 | Glencore Buy | Jefferies & Company Inc. | |
| 22.02.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 22.02.24 | HSBC Holdings Buy | Deutsche Bank AG | |
| 22.02.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 21.02.24 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 21.02.24 | BAT Neutral | UBS AG | |
| 21.02.24 | HSBC Holdings Overweight | Barclays Capital | |
| 21.02.24 | Glencore Equal Weight | Barclays Capital | |
| 21.02.24 | Rio Tinto Overweight | Barclays Capital | |
| 21.02.24 | Glencore Buy | Jefferies & Company Inc. | |
| 21.02.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.02.24 | Glencore Outperform | RBC Capital Markets | |
| 21.02.24 | Glencore Buy | UBS AG | |
| 21.02.24 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 21.02.24 | Rio Tinto Neutral | UBS AG | |
| 21.02.24 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 21.02.24 | HSBC Holdings Sector Perform | RBC Capital Markets | |
| 21.02.24 | GSK Buy | Deutsche Bank AG | |
| 21.02.24 | HSBC Holdings Buy | Jefferies & Company Inc. | |
| 21.02.24 | HSBC Holdings Neutral | UBS AG | |
| 21.02.24 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 20.02.24 | BP Underweight | JP Morgan Chase & Co. | |
| 20.02.24 | Shell Overweight | JP Morgan Chase & Co. | |
| 20.02.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.24 | HSBC Holdings Neutral | JP Morgan Chase & Co. | |
| 19.02.24 | BAT Overweight | Barclays Capital | |
| 19.02.24 | Unilever Overweight | Barclays Capital | |
| 19.02.24 | AstraZeneca Sell | UBS AG | |
| 19.02.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 19.02.24 | Shell Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 16.02.24 | AstraZeneca Hold | Jefferies & Company Inc. |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.